Research

Clinical Studies are being conducted to investigate the safety and efficacy of the BrainPort balance device.

Preliminary studies show promising results for people with balance deficits due to vestibular dysfunction.

To learn more about current clinical research opportunities, visit Clinical Trials.

General Clinical Trial Information

•	Prior to beginning a clinical trial, the study is carefully reviewed and approved within each clinical site by an Institutional Review Board, which includes doctors, administrators, ethicists and members of the general public.
•	All volunteers for clinical trials must meet the trial inclusion and exclusion criteria and sign a consent form that describes the purpose of the trial, its duration, the procedures used, benefits and risks of the study. Volunteers may leave a clinical trial at any time without penalty.
•	Subject and patient confidentiality is fully protected. Patient identifying information and data collected will not be accessible outside of the clinical site without written permission by the volunteer.

The BrainPort balance device is an Investigational Device and its use remains limited by U.S. Federal Law to investigational uses only. The US FDA 510(k) PreMarket Notification for the BrainPort Balance device is currently pending. WICAB MAKES NO REPRESENTATIONS REGARDING THE DEVICE SAFETY OR EFFICACY.